Drugs / COBI
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01440569 | Sep 2011 → Aug 2012 | AIDS | Gilead Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COBI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01440569 ↗ |
| Route | Oral | “150 mg tablet administered orally with food once daily” NCT01440569 ↗ |